Lite Strategy Inc (LITS) Stock Price, Quote & News

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 858 369 7100

Website: www.litestrategy.com

Address:

9920 Pacific Heights Blvd., Suite 150, San Diego, United States

Statistical Dec. 31 at 5:12 PM

$LITS there’s a reason they aren’t buying… they are paying themselves with your buys and will continue to dilute you dumbies.

0 · Reply

R3JS Dec. 30 at 3:23 PM

$BTC.X $LITS $LTC.X Top trending award to LTC and actually is a pretty good article with some good bullet points and I am in it for the Lester comment of all things.

0 · Reply

GutTrades Dec. 30 at 12:42 PM

$BTC.X $LITS $LTC.X

0 · Reply

Guam_671 Dec. 30 at 11:27 AM

$LITS is this a buy at $1.21?

0 · Reply

StocktwitsNews Dec. 30 at 8:52 AM

Bitcoin’s ‘Digital Silver’ Cousin Tops Retail Interest After Outperforming Major Tokens $LTC.X $LITS $BTC.X https://stocktwits.com/news/cryptocurrency/markets/bitcoin-s-digital-silver-cousin-tops-retail-interest-after-outperforming-major-tokens/cL74ur4REUB

0 · Reply

Oggy23 Dec. 29 at 7:10 PM

$LITS c‘mon get LITS

0 · Reply

soccerplayer06 Dec. 27 at 11:48 PM

$LTC.X she’s a hot ticket. $LITS

0 · Reply

soccerplayer06 Dec. 27 at 2:54 PM

$LTC.X $LITS When is Lite Strategy going to add to the Litecoin ecosystem? Nothing announced since months ago when they bought 929k litecoins… waiting…

0 · Reply

LostSun Dec. 26 at 10:30 PM

$LITS Could have stock piled tons of actual silver but they got scammed into buying a 100 million dollars worth of litecoin LMAO

1 · Reply

SuperGreenToday Dec. 26 at 9:02 PM

$LITS Share Price: $1.34 Contract Selected: Jun 18, 2026 $2.5 Calls Buy Zone: $0.13 – $0.16 Target Zone: $0.21 – $0.26 Potential Upside: 56% ROI Time to Expiration: 173 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Aug 5, 2025, 8:00 AM EDT - 5 months ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Jul 24, 2025, 8:00 PM EDT - 5 months ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 22, 2025, 4:35 PM EDT - 5 months ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 1:22 PM EDT - 5 months ago

Why Is MEI Pharma Stock Soaring On Friday?

Jul 18, 2025, 8:30 AM EDT - 5 months ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

May 13, 2025, 4:05 PM EDT - 8 months ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 4:12 PM EST - 11 months ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Aug 12, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma to Consider Strategic Alternatives

May 14, 2024, 10:38 AM EDT - 1 year ago

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

May 9, 2024, 4:02 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Apr 11, 2024, 8:02 AM EDT - 1 year ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 10, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

$MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia$

Mar 26, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Feb 13, 2024, 5:05 PM EST - 2 years ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Jan 16, 2024, 5:00 PM EST - 2 years ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Sep 28, 2023, 5:00 PM EDT - 2 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 26, 2023, 7:47 PM EDT - 2 years ago

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

Sep 26, 2023, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 21, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Aug 16, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Jul 23, 2023, 2:30 PM EDT - 2 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 19, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 18, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Responds to Anson and Cable Car

Jul 17, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 13, 2023, 4:05 PM EDT - 2 years ago

MEI Pharma Postpones Special Meeting of Shareholders

Jul 11, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 5, 2023, 8:30 AM EDT - 2 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 15, 2023, 12:08 PM EDT - 2 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 14, 2023, 7:01 PM EDT - 2 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 13, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

Jun 2, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

Jun 1, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Board of Directors Rejects Unsolicited Proposal

May 30, 2023, 5:40 PM EDT - 2 years ago

MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal

Statistical Dec. 31 at 5:12 PM

$LITS there’s a reason they aren’t buying… they are paying themselves with your buys and will continue to dilute you dumbies.

0 · Reply

R3JS Dec. 30 at 3:23 PM

$BTC.X $LITS $LTC.X Top trending award to LTC and actually is a pretty good article with some good bullet points and I am in it for the Lester comment of all things.

0 · Reply

GutTrades Dec. 30 at 12:42 PM

$BTC.X $LITS $LTC.X

0 · Reply

Guam_671 Dec. 30 at 11:27 AM

$LITS is this a buy at $1.21?

0 · Reply

StocktwitsNews Dec. 30 at 8:52 AM

0 · Reply

Oggy23 Dec. 29 at 7:10 PM

$LITS c‘mon get LITS

0 · Reply

soccerplayer06 Dec. 27 at 11:48 PM

$LTC.X she’s a hot ticket. $LITS

0 · Reply

soccerplayer06 Dec. 27 at 2:54 PM

$LTC.X $LITS When is Lite Strategy going to add to the Litecoin ecosystem? Nothing announced since months ago when they bought 929k litecoins… waiting…

0 · Reply

LostSun Dec. 26 at 10:30 PM

$LITS Could have stock piled tons of actual silver but they got scammed into buying a 100 million dollars worth of litecoin LMAO

1 · Reply

SuperGreenToday Dec. 26 at 9:02 PM

0 · Reply

Guam_671 Dec. 26 at 1:42 PM

$LITS have a limit buy sitting at $1.21…, hoping the company puts out some news next week, the week of 29 December 2025 to send this up. Short term bull…

0 · Reply

ClarityCap Dec. 25 at 9:57 AM

$LITS Forward momentum is increasingly dictated by operational clarity, while management calibrates resource allocation to real demand signals. Shortfalls would likely reprice expectations quickly.

0 · Reply

Statistical Dec. 24 at 9:00 PM

$LITS i hope someone files a class action lawsuit against them.

1 · Reply

Statistical Dec. 24 at 8:58 PM

$LITS once again it doesn’t take a rocket scientist to have seen where this was going. They just grabbed the last remaining liquidity from Litecoin retail investors and are running away with millions of dollars to ditch their pharma company. If you fell for this you’re a complete idiot

1 · Reply

soccerplayer06 Dec. 24 at 12:38 PM

$LTC.X added more here… again. History has shown buying in the 80’s and lower has been a good area to accumulate at. waiting for the $1,000 plus price tag to finally let some go. $LITS Still waiting on LITS to make another move.

3 · Reply

onemillion2012 Dec. 24 at 10:04 AM

$LITS $ASMB i think The German master Alexander S. Have sild out of both Asmb and lits. Can be no other then margin call. He paid top Dollar for $LITS and sold out at forever low price

0 · Reply

rac0258 Dec. 24 at 10:02 AM

$LTC.X $LUXFF $LUXX.CSE $LITS New news released by LitVM. There has been some discussions about what the “Yeild” will look like for Litecoin and one thing was clear. Coins lent to exchanges are being used to wipe out leveraged positions, which created fear, insecurity, and price suppression. LitVM will allow you to keep your coins. Yeild will be earned on chain for those who choose to lend their coins to an on chain coin swap, which increases liquidity. It will be done through transaction fees. The busier it is, the more Yeild you earn. And we all know Litecoin is busy. https://x.com/circle_crypto/status/2003637551416975404?s=46

0 · Reply

Statistical Dec. 23 at 2:39 PM

$LITS man you people are idiots 😂😂

0 · Reply

FilingTracker Dec. 22 at 9:20 PM

$LITS Much larger insider sale: https://www.sec.gov/Archives/edgar/data/1262104/000107997325001891/xslF345X05/ownership.xml

2 · Reply

FilingTracker Dec. 22 at 9:02 PM

$LITS Insider purchase: https://www.sec.gov/Archives/edgar/data/1262104/000119312525328666/xslF345X05/ownership.xml

0 · Reply

soccerplayer06 Dec. 22 at 1:17 PM

$LITS so when is the share repurchasing going to begin??

2 · Reply

dogbone80 Dec. 18 at 11:46 PM

$LITS OMG everyone is bearish!!!!! You know what that means...

0 · Reply

Market Cap	48.92M
Revenue (ttm)	0.00
Net Income (ttm)	-15.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,683,900
Avg Vol	602,326
Day's Range	N/A - N/A
Shares Out	36.79M
Stochastic %K	34%
Beta	0.23
Analysts	Hold
Price Target	N/A